ASCOT-BPLA.
Goldstein
Mark R
MR
D017311:Amlodipine / Q000009:adverse effects* / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D009369:Neoplasms / Q000139:chemically induced*; D016032:Randomized Controlled Trials as Topic
D002121:Calcium Channel Blockers; D017311:Amlodipine